Identification markers |
CCR3 |
Basophils, mast cells, Th2 lymphocytes |
Stable marker for identification, may need further differentiation from other cells such as use of CD3 |
[6–9] |
CD203c |
Basophils, mast cells, CD34+ progenitor cells |
Widely used identification marker and expressed in low levels of resting cells. Upregulation has been reported to be representative of piecemeal degranulation |
[10, 11] |
CD123 |
Basophils, plasmacytoid dendritic cells |
Highly expressed in these cells; HLA-DR can be used to differentiate between HLA-DR+ dendritic cells |
[12, 13] |
IgE |
Basophils, monocytes, dendritic cells |
Other cells expressing high affinity IgE receptor FcɛRI can be differentiated by also using HLA-DR. High variability in individuals has been reported |
[6, 14] |
CRTH2 |
Basophils, eosinophils, Th2 lymphocytes |
Differentiation from eosinophils by side scatter or T lymphocytes by CD3 is reported |
[15] |
Activation markers |
CD63 |
Basophils, mast cells, platelets, macrophages |
Widely used activation marker and an accurate marker of anaphylactic degranulation |
[7, 11, 16, 17••] |
CD107a, CD107b |
Various cell types including basophils, mast cells, T cells and NK cells |
CD107a and CD107b was found to be only expressed by activated basophils and its upregulation was similar to CD63. CD13 and CD164 has an expression profile comparable to CD203c |
[18] |
CD13 |
Basophils, myeloid cells |
CD164 |
Basophils, CD34+ progenitor cells |
CD69 |
Basophils, lymphocytes, neutrophils, monocytes, eosinophils |
Expressed progressively when stimulated with IL-3; however, found to be weakly expressed to IgE mediated stimulation |
[19, 20] |
p38 MAPK, STAT5 |
Various cell types |
Basophilic phosphorylation of intracellular molecules can alternatively be used to measure basophil activation |
[21, 22] |